Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bruce D, Behounek"'
Autor:
Elliott M. Antman, Charles Lazzam, Robert J. Carney, Raymond G. McKay, Govinda Weerakkody, Stephen D. Wiviott, Kenneth J. Winters, Sabina A. Murphy, Eugene Braunwald, Bruce D. Behounek, Carolyn H. McCabe
Publikováno v:
Circulation. 111:3366-3373
Background— Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention patients, periprocedural and postprocedural ischemic events continue t
Autor:
Julio Rosenstock, Sherwyn Schwartz, Om P. Ganda, Bruce D. Behounek, Michael D. Cressman, Bonnie H. Weiner, Gabriella G. Cucinotta, Mark E. McGovern, D. A. Willard, Beverly Phillipson, Peter A. Lodewick, Jean Norton, Philip Raskin
Publikováno v:
The American Journal of Medicine. 99:362-369
PURPOSE Patients with type I and type II diabetes mellitus have an increased risk of coronary heart disease. In many diabetics, hypercholesterolemia is present and further exacerbates this risk. We investigated the efficacy and safety of pravastatin
Autor:
Michael Bergman, Bruce D. Behounek, S. Jeffrey Markowitz, Mark E. McGovern, Kenneth Kassler-Taub
Publikováno v:
Clinical Cardiology. 17:558-562
This multinational, 16-week, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of low-dose pravastatin in 325 patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypercholesterolemia [serum total chole
Autor:
Stephen D, Wiviott, Elliott M, Antman, Kenneth J, Winters, Govinda, Weerakkody, Sabina A, Murphy, Bruce D, Behounek, Robert J, Carney, Charles, Lazzam, Raymond G, McKay, Carolyn H, McCabe, Eugene, Braunwald
Publikováno v:
Circulation. 111(25)
Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention patients, periprocedural and postprocedural ischemic events continue to occur. Prasu
Autor:
Frances E. Broyles, Bruce D. Behounek, Evan A. Stein, Robert H. Knopp, Henry N. Ginsberg, D. Roger Illingworth
Publikováno v:
American journal of therapeutics. 3(11)
OBJECTIVE: To determine the efficacy and safety of pravastatin in the treatment of subjects with Type III hyperlipoproteinemia. DESIGN: Randomized, double-blind, placebo-controlled, crossover study. SETTING: Four lipid research clinics in the United
Autor:
Bruce D. Behounek, John T. Santinga, James J. Maciejko, Howard S. Rosman, Lester Kobylak, Melvyn Rubenfire, Mark E. McGovern
Publikováno v:
The American journal of medicine. 96(6)
purpose: Elevated cholesterol levels are a major risk factor for coronary heart disease, which remains a significant problem in patients beyond age 65 years. Because drug therapy for the control of hypercholesterolemia in elderly patients is frequent